Cargando…
Time to Rethink the Current Paradigm for Assessing Kidney Function in Drug Development and Beyond
Chronic kidney disease (CKD) is an important health issue that affects ~ 9.1% of the world adult population. Serum creatinine is the most commonly used biomarker for assessing kidney function and is utilized in different equations for estimating creatinine clearance or glomerular filtration rate (GF...
Autores principales: | Sharma, Ashish, Sahasrabudhe, Vaishali, Musib, Luna, Zhang, Steven, Younis, Islam, Kanodia, Jitendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786617/ https://www.ncbi.nlm.nih.gov/pubmed/34800044 http://dx.doi.org/10.1002/cpt.2489 |
Ejemplares similares
-
Best Practices for the Development, Scale-up, and Post-approval Change Control of IR and MR Dosage Forms in the Current Quality-by-Design Paradigm
por: Van Buskirk, Glenn A., et al.
Publicado: (2014) -
Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges
por: Geerts, Hugo, et al.
Publicado: (2019) -
Current status of the multinational Arabidopsis community
por: Parry, Geraint, et al.
Publicado: (2020) -
In and Beyond COVID-19: US Academic Pharmaceutical Science and Engineering Community Must Engage to Meet Critical National Needs
por: Gurvich, Vadim J., et al.
Publicado: (2020) -
Arabidopsis bioinformatics resources: The current state, challenges, and priorities for the future
Publicado: (2019)